What Biotech Innovation Needs
The rapid delivery of vaccines against COVID-19 has heightened everyone’s appreciation for biotech research and development, leading some governments to embark on a quest for “life-science sovereignty.” But to strengthen their capacity for medical innovation, policymakers will need to heed the lessons of past success stories.
https://prosyn.org/v2GlJAT
CAMBRIDGE – The COVID-19 pandemic has reshaped attitudes toward public health, fiscal policy, and the state’s role in the economy. Demands for greater supply-chain resilience and strategic autonomy in developing and producing medicines have given rise to the concept of “life-science sovereignty.”